• LAST PRICE
    15.86
  • TODAY'S CHANGE (%)
    Trending Up0.43 (2.79%)
  • Bid / Lots
    13.69/ 3
  • Ask / Lots
    17.20/ 10
  • Open / Previous Close
    15.90 / 15.43
  • Day Range
    Low 15.70
    High 15.91
  • 52 Week Range
    Low 9.22
    High 17.96
  • Volume
    5,955
    below average
  • Overall Morningstar Rating
    1 out of 5 Stars
    out of 265 funds

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 15.43
TimeVolumeCNCR
09:32 ET102315.9
10:30 ET10015.91
11:02 ET10015.815
12:16 ET47015.7816
12:56 ET70015.789
01:12 ET10015.7408
01:14 ET31715.71
03:07 ET160015.7
03:39 ET10015.83
03:45 ET20015.72
03:54 ET10015.87
03:57 ET31815.82
03:59 ET015.86
Data delayed at least 15 minutes.

Daily Premium/Discount

Bar Graph.See accessible table below
Daily Premium/Discount accessibility chart. Data as of 5/3/2024
DateDaily Premium/Discount
02/05/2024 -0.20%
02/06/2024 0.15%
02/07/2024 0.55%
02/08/2024 0.36%
02/09/2024 -0.27%
02/12/2024 -0.64%
02/13/2024 -0.42%
02/14/2024 0.32%
02/15/2024 -0.04%
02/16/2024 0.25%
02/20/2024 0.45%
02/21/2024 -0.14%
02/22/2024 -0.24%
02/23/2024 0.24%
02/26/2024 0.31%
02/27/2024 0.84%
02/28/2024 0.62%
02/29/2024 0.72%
03/01/2024 0.93%
03/04/2024 0.77%
03/05/2024 -0.49%
03/06/2024 0.08%
03/08/2024 0.28%
03/11/2024 -0.25%
03/12/2024 Largest Premium1.12%
03/13/2024 0.43%
03/14/2024 0.29%
03/15/2024 -0.01%
03/18/2024 0.79%
03/19/2024 -0.20%
03/20/2024 Largest Discount-0.82%
03/21/2024 0.19%
03/22/2024 -0.26%
03/25/2024 0.30%
03/26/2024 -0.28%
03/27/2024 -0.09%
03/28/2024 0.07%
04/01/2024 -0.55%
04/02/2024 -0.10%
04/03/2024 0.54%
04/04/2024 -0.29%
04/05/2024 0.68%
04/09/2024 -0.12%
04/10/2024 -0.60%
04/11/2024 -0.03%
04/12/2024 0.79%
04/15/2024 -0.38%
04/16/2024 -0.52%
04/17/2024 -0.21%
04/18/2024 -0.36%
04/19/2024 -0.61%
04/22/2024 -0.42%
04/23/2024 -0.38%
04/24/2024 -0.44%
04/25/2024 -0.28%
04/26/2024 -0.35%
04/29/2024 -0.43%
04/30/2024 -0.28%
05/01/2024 0.59%
05/02/2024 -0.58%
ETFs trading at a price higher than its Net Asset Value (NAV) is said to be trading at a premium, while those trading at price lower than its NAV is said to be at a discount. By showing the daily premium/discount percentage, we can see the trend in market sentiments, regarding the value of an ETF over time.
Asset Class
Asset Class
US Stock
86.3%
Non-US Stock
13.5%
Cash
0.2%
Convertible
0
Non-US Bond
0
Other
0
Sectors
Sectors
Healthcare99.8%
Basic Mat.0
Communication Services0
Consumer Cyclical0
Consumer Defensive0
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
Geographic Region
United States
86.5%
Europe
6.4%
Asia/Oceania
1.5%
Canada
0.8%
Africa
0
Latin America
0
As of 2024-04-30
Top 10 Holdings
Company Name sortablePosition sortableAllocation sortable
Allocation
1 Month Change
sortable
Market Value sortable
United StatesGERN
Geron Corp
Long
3.0%
0.00%
$532.0K
United StatesACRV
Acrivon Therapeutics Inc
Long
2.4%
0.00%
$424.7K
United StatesIBRX
ImmunityBio Inc Ordinary Shares
Long
2.2%
0.00%
$385.5K
United StatesCGEM
Cullinan Therapeutics Inc
Long
2.2%
0.00%
$378.4K
United StatesDCPH
Deciphera Pharmaceuticals Inc
Long
2.2%
0.00%
$376.3K
United StatesJANX
Janux Therapeutics Inc Ordinary Shares
Long
2.0%
0.00%
$357.6K
United StatesELVN
Enliven Therapeutics Inc
Long
2.0%
0.00%
$357.0K
United StatesNUVB
Nuvation Bio Inc Ordinary Shares - Class A
Long
1.9%
0.00%
$323.4K
United StatesDAWN
Day One Biopharmaceuticals Inc
Long
1.6%
0.00%
$285.5K
United StatesRVMD
Revolution Medicines Inc Ordinary Shares
Long
1.6%
0.00%
$276.2K
As of 2024-05-03

Reports

  • Morningstar ETF Report

    The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.

Morningstar Ratings

Morningstar Ratings Table
Time HorizonStar Rating
Overall Rating
1 out of 5 Stars
3 Year Rating
1 out of 5 Stars
5 Year Rating
1 out of 5 Stars
10 Year RatingPlease Note: Not Rated
As of 2024-04-30

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
Range Cancer Therapeutics USD
Category
Sponsor
Exchange Traded Concepts, LLC
Inception
October 13, 2015
As of 2024-04-30

The investment seeks to track the performance, before fees and expenses, of the Range Cancer Therapeutics Index (the “index”). The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts (“ADRs”) with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund’s total assets will be invested in the component securities of the index.

Holding Details
Total Net Assets$17.5M
Shares Out.1.2M
Net Asset Value (NAV)$15.52
Prem/Discount to NAV-0.58%
P/E Ratio---
Dividend Yield0.00%
Dividend per Share---
Ex-Dividend Date---
Dividend Payment Date---
Beta---
Morningstar Investment StyleHealth
Equity Style
Small Cap Blend
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.79%
Actual Mgmt. Expense Ratio (MER)0.79%